IceCure (ICCM) VP Good Shad Receives 131,483 RSU Award

What Happened

• Good Shad, Vice President, Sales for North America at IceCure Medical Ltd. (ICCM), was granted 131,483 restricted share units (RSUs) on August 14, 2026. The award was granted at $0.00 per share (award/compensation), so no cash was paid.
• After this grant, the filing discloses total reported holdings of 136,698 securities consisting of 219 ordinary shares and 136,479 RSUs (the sum of the new grant plus prior RSU grants). The total reported acquisition value for the grant is $0.

Key Details

• Transaction date and filing: Grant on 2026-08-14; Form 4 filed 2026-08-17 (timely filing).
• Award terms: 131,483 RSUs granted 8/14/2026. Vesting: 25% vests on August 11, 2027; remaining 75% vests in twelve equal quarterly installments of 6.25% thereafter.
• Prior holdings included: 219 ordinary shares and prior RSU grants (2,021 RSUs from 7/2/2024, 1,757 RSUs from 11/5/2025, and 1,218 RSUs from 3/16/2026). Of the prior grants, the 25% tranche of the 7/2/2024 RSUs vested on July 29, 2026; otherwise the RSUs were unvested as of 8/13/2026.
• Adjustment: Holdings in clauses (ii)–(v) were adjusted to reflect the issuer’s 1-for-30 reverse share split.
• Transaction type code: A = Award/Grant (not an open-market purchase or sale).

Context

• This was a compensation grant (RSUs), not a purchased stake — such awards are common for employee retention and do not necessarily indicate a buy/sell signal. Most of the newly granted RSUs are subject to multi-year vesting and remain unvested initially.